mnexspike covid - Search News

News

Moderna, COVID-19 and mNexspike

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.

Clinical Advisor · 4h

FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that puts them at high risk.

What to know about Moderna’s new ‘mNexspike’ COVID-19 vaccine

From eligibility to dosage and future rollout, here’s what you need to know about the FDA’s latest vaccine approval.

McKnight's Long-Term Care News3d

New COVID-19 vaccine for older adults gets FDA nod as fresh variant emerges

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...

2don MSN

RFK Jr. says Moderna agreed to another clinical trial to support new COVID shot

HHS Secretary Robert F. Kennedy Jr. says Moderna (MRNA) has agreed to do another clinical trial to back its newly approved ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results